The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
p38 MAP kinase: a convergence point in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T., & Nebreda, A. R. (1994) · Cell · doi:10.1016/0092-8674(94)90277-1 · Cited by 1,674
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases
Kumar, S., Boehm, J., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,197
Wang, X., & Ron, D. (1996) · Science · doi:10.1126/science.272.5266.1347 · Cited by 883
Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
Han, J., Jiang, Y., Li, Z., Kravchenko, V. V., & Ulevitch, R. J. (1997) · Nature · doi:10.1038/386296a0 · Cited by 766
Bulavin, D. V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6845 · Cited by 711
Components of a New Human Protein Kinase Signal Transduction Pathway
Zhou, G., Bao, Z. Q., & Dixon, J. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12665 · Cited by 639
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592
An Osmosensing Signal Transduction Pathway in Mammalian Cells
Galcheva-Gargova, Z., Dérijard, B., Wu, I.-H., & Davis, R. J. (1994) · Science · doi:10.1126/science.8047888 · Cited by 568
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
Weijzen, S., Rizzo, P., Braid, M., Vaishnav, R., Jonkheer, S. M., Zlobin, A., Osborne, B. A., Gottipati, S., Aster, J. C., Hahn, W. C., et al. (2002) · Nature Medicine · doi:10.1038/nm754 · Cited by 550
Enslen, H., Raingeaud, J., & Davis, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1741 · Cited by 539
p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic Potentials
Lee, J. C., Kassis, S., Kumar, S., Badger, A., & Adams, J. L. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00008-x · Cited by 348
van der Houven van Oordt, W., Diaz-Meco, M. T., Lozano, J., Krainer, A. R., Moscat, J., & Cáceres, J. F. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.307 · Cited by 345
Primary Structure of BMK1: A New Mammalian MAP Kinase
Lee, J. D., Ulevitch, R. J., & Han, J. H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2189 · Cited by 342
Hildesheim, J., Bulavin, D. V., Anver, M. R., Alvord, W. G., Hollander, M. C., Vardanian, L., & Fornace, A. J. (2002) · PubMed · Cited by 283
Crystal Structure of p38 Mitogen-activated Protein Kinase
Wilson, K. P., Fitzgibbon, M. J., Caron, P. R., Griffith, J. P., Chen, W., McCaffrey, P. G., Chambers, S. P., & Su, M. S.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27696 · Cited by 262
Puri, P. L., Wu, Z., Zhang, P., Wood, L. D., Bhakta, K. S., Han, J., Feramisco, J. R., Karin, M., & Wang, J. Y. J. (2000) · Genes & Development · doi:10.1101/gad.14.5.574 · Cited by 244
Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306248200 · Cited by 239
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect
Hallahan, A. R., Pritchard, J. I., Chandraratna, R. A. S., Ellenbogen, R. G., Geyer, J. R., Overland, R. P., Strand, A. D., Tapscott, S. J., & Olson, J. M. (2003) · Nature Medicine · doi:10.1038/nm904 · Cited by 192
Self-citationKim, M., Lee, E.-J., Kim, H.-R. C., & Moon, A. (2003) · PubMed · Cited by 190
p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability
Issbrücker, K., Martin, H. H., Hippenstiel, S., Springmann, G., Voswinckel, R., Gaumann, A., Breier, G., Drexler, H. C. A., Suttorp, N., & Clauss, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0329fje · Cited by 179
Role of the p38 MAPK pathway in cisplatin-based therapy
Losa, J. H., Cobo, C. P., Viniegra, J. G., Lobo, V. J. S.-A., Cajal, S. R. Y., & Sánchez-Prieto, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206608 · Cited by 166
Deacon, K., Mistry, P., Chernoff, J., Blank, J. L., & Patel, R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-10-0653 · Cited by 164
Abe, M. K., Kuo, W.-L., Hershenson, M. B., & Rosner, M. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1301 · Cited by 159
Involvement of the p38 mitogen‐activated protein kinase cascade in hepatocellular carcinoma
Iyoda, K., Sasaki, Y., Horimoto, M., Toyama, T., Yakushijin, T., Sakakibara, M., Takehara, T., Fujimoto, J., Hori, M., Wands, J. R., et al. (2003) · Cancer · doi:10.1002/cncr.11425 · Cited by 152
Zelivianski, S., Spellman, M., Kellerman, M., Kakitelashvilli, V., Zhou, X., Lugo, E., Lee, M., Taylor, R., Davis, T. L., Hauke, R. J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11413 · Cited by 151
Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis Inhibitors
Lee, J. C., Badger, A. M., Griswold, D. E., Dunnington, D. J., Truneh, A., Votta, B. J., White, J. R., Young, P. R., & Bender, P. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17149.x · Cited by 145
Shimada, K., Nakamura, M., Ishida, E., Kishi, M., & Konishi, N. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg058 · Cited by 136
ERK8, a New Member of the Mitogen-activated Protein Kinase Family
Abe, M. K., Saelzler, M. P., Espinosa, R., Kahle, K. T., Hershenson, M. B., Beau, M. M. L., & Rosner, M. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112483200 · Cited by 127
Park, M.-T., Choi, J.-A., Kim, M.-J., Um, H., Bae, S., Kang, C.-M., Cho, C.-K., Kang, S., Chung, H. Y., Lee, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309011200 · Cited by 126
Jung, Y. D., Liu, W., Reinmuth, N., Ahmad, S. A., Fan, F., Gallick, G. E., & Ellis, L. M. (2001) · Angiogenesis · doi:10.1023/a:1012291524723 · Cited by 115
Regulation of p73 by c-Abl through the p38 MAP kinase pathway
Sánchez‐Prieto, R., Lobo, V. J. S.-A., Servitja, J., & Gutkind, J. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205134 · Cited by 113
p38 Mitogen-Activated Protein Kinases on the Body Surface – A Function for p38δ
Eckert, R. L., Efimova, T., Balasubramanian, S., Crish, J. F., Bone, F., & Dashti, S. R. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12120.x · Cited by 92
Holmes, W. F., Soprano, D. R., & Soprano, K. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206694 · Cited by 75
p38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival
Yılmaz, A., Kliche, S., Mayr-Beyrle, U., Fellbrich, G., & Waltenberger, J. L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01064-7 · Cited by 75
Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2
McMullen, M. E., Keller, R. S., Sussman, M. A., & Pumiglia, K. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207243 · Cited by 68
Okadaic Acid and Anisomycin are Protective and Stimulate the SAPK/JNK Pathway
Barančík, M., Htun, P., & Schaper, W. K. A. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199908000-00002 · Cited by 62
Gianni’, M., Kopf, E., Bastien, J., Oulad‐Abdelghani, M., Garattini, E., Chambon, P., & Rochette‐Egly, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200230200 · Cited by 61
Lee, T., Kim, S. J., & Sumpio, B. E. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10211 · Cited by 53
p38 Mitogen-Activated Protein Kinase Regulates Bax Translocation in Cyanide-Induced Apoptosis
Shou, Y., Li, L., Prabhakaran, K., Borowitz, J. L., & Isom, G. E. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg157 · Cited by 51
Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukaemia
Levy‐Nissenbaum, O., Sagi‐Assif, O., Raanani, P., Avigdor, A., Ben‐Bassat, I., & Witz, I. P. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00352-5 · Cited by 29
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
Sui, X., Kong, N., Ye, L., Han, W., Zhou, J., Zhang, Q., He, C., & Pan, H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.019 · Cited by 958
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
Metadata
- Authors
- Olson, J. M., & Hallahan, A. R.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 10
- Issue
- 3
- Pages
- 125-129
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1972304405
- Cited by
- 335
- References
- 46
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.